This seed funding comes after GEMMABio secured $100m in October through a partne...
The FDA initially rejected the marketing application for Alhemo in 2022, asking ...
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive...
AstraZeneca has gained approval from the European Commission for its oral therap...
Lilly’s Zepbound has become the first prescription medicine approved to treat ad...
SK bioscience and Sanofi have expanded their agreement to jointly develop pneumo...
Welcome to WordPress. This is your first post. Edit or delete it, then start wri...
Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjuncti...
Roche’s 2019 acquisition of Philadelphia-based gene therapy specialist Spark The...
Danish pharmaceutical company Novo Nordisk has received approval from the Europe...
Danish pharmaceutical giant Novo Nordisk announced plans to invest 8.5 billion D...
Palleon and Henlius Biotech have entered into a licence agreement and partnershi...
Astellas Pharma and Sangamo have signed a licence agreement for neurotropic aden...
In this issue: Recent US reproductive laws could limit women’s participation in ...
Vertex said the Phase II trial met its primary endpoint, however there was only ...
Mesoblast has gained US FDA approval for its mesenchymal stromal cell (MSC) ther...
